Search Within

Darren Richard Feldman

Formats
  1. Journal Article (189)
  2. Meeting Abstract (142)
  3. Book Section (6)
  4. Review (6)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Department of Medicine (349)
  2. Genitourinary Oncology Service (349)
  3. Solid Tumor Oncology Division (349)
  4. Survivorship Research (125)
  5. Surgery (114)
  6. Epidemiology and Biostatistics (112)

More Groups

People
  1. Robert Motzer (158)
  2. George Bosl (86)
  3. Martin Voss (81)
  4. Sujata Patil (81)
  5. Joel Sheinfeld (68)
  6. Chung-Han Lee (55)

More People

Years
  1. 2025 (16)
  2. 2024 (24)
  3. 2023 (20)
  4. 2022 (21)
  5. 2021 (25)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (148)
  2. Urology (13)
  3. Clinical Genitourinary Cancer (11)
  4. Cancer (10)
  5. Clinical Cancer Research (9)
  6. Investigational New Drugs (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (154)
  2. Elsevier Science, Inc. (29)
  3. Elsevier Inc. (28)
  4. Wiley Blackwell (20)
  5. Oxford University Press (18)
  6. American Association for Cancer Research (17)

More Publishers

Results (349)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib versus sunitinib for untreated patients with advanced renal cell carcinoma of intermediate or poor risk: Subgroup analysis of the Alliance A031203 CABOSUN trial
    Journal Article

    George, D. J.; Hessel, C.; Halabi, S.; Michaelson, M. D.; Hahn, O.; Walsh, M.; Picus, J.; Small, E. J.; Dakhil, S.; Feldman, D. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Impact of cisplatin-related adverse health outcomes (AHOs) on employment outcomes and self-reported health (SRH) among testicular cancer survivors (TCS)
    Meeting Abstract

    Kerns, S. L.; Fung, C.; Fossa, S. D.; Dinh, P. C.; Monahan, P. O.; Sesso, H. D.; Frisina, R. D.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)
    Meeting Abstract

    Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J. S.; Patil, S.; Reuter, V. E.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Milowsky, M. I.; Appleman, L. J.; Dorff, T. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Second solid (SMN) and hematologic malignant neoplasms (HMN) among 24,900 United States testicular cancer survivors (TCS) after chemotherapy (CHEM), radiotherapy (RT), or surgery only (SURG)
    Meeting Abstract

    Abu Zaid, M. I.; Milano, M. T.; Dinh, P. C.; Fossa, S.; Yang, H.; Feldman, D. R.; Travis, L. B.; Fung, C.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) arising from teratoma in late relapse germ cell tumor (GCT)
    Meeting Abstract

    Wong, N. C.; Dason, S.; Dean, L. W.; Isharwal, S.; Donoghue, M.; Jia, L.; Joseph, G.; Tap, W. D.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Di Natale, R. G.; Chowell, D.; Makarov, V.; Redzematovic, A.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT)
    Meeting Abstract

    Dean, L. W.; Wong, N. C.; Dason, S.; Isharwal, S.; Donoghue, M.; Jia, L.; Tap, W. D.; Joseph, G.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save